These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32863097)

  • 1. Quality of advanced ovarian cancer surgery: A French assessment of ESGO quality indicators.
    Gac MM; Loaec C; Silve J; Vaucel E; Augereau P; Wernert R; Bourgin C; Aireau X; Lortholary A; Descamps P; Priou F; Deblaye P; Bourgeois H; Delecroix V; Empereur F; Campion L; Classe JM
    Eur J Surg Oncol; 2021 Feb; 47(2):360-366. PubMed ID: 32863097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery.
    Querleu D; Planchamp F; Chiva L; Fotopoulou C; Barton D; Cibula D; Aletti G; Carinelli S; Creutzberg C; Davidson B; Harter P; Lundvall L; Marth C; Morice P; Rafii A; Ray-Coquard I; Rockall A; Sessa C; van der Zee A; Vergote I; du Bois A
    Int J Gynecol Cancer; 2016 Sep; 26(7):1354-63. PubMed ID: 27648648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update.
    Fotopoulou C; Concin N; Planchamp F; Morice P; Vergote I; du Bois A; Querleu D
    Int J Gynecol Cancer; 2020 Apr; 30(4):436-440. PubMed ID: 32086362
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe Francaise d'Oncologie Gynecologique, SFOG).
    Querleu D; Ray-Coquard I; Classe JM; Aucouturier JS; Bonnet F; Bonnier P; Darai E; Devouassoux M; Gladieff L; Glehen O; Haie-Meder C; Joly F; Lécuru F; Lefranc JP; Lhommé C; Morice P; Salengro A; Stoeckle E; Taieb S; Zeng ZX; Leblanc E
    Ann Oncol; 2013 Nov; 24(11):2732-9. PubMed ID: 23857961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN).
    Jochum F; De Rozario T; Lecointre L; Faller E; Boisrame T; Dabi Y; Lavoué V; Coutant C; Touboul C; Bolze PA; Bricou A; Canlorbe G; Collinet P; Huchon C; Bendifallah S; Ouldamer L; Mezzadri M; Querleu D; Akladios C
    Int J Gynecol Cancer; 2021 Nov; 31(11):1443-1452. PubMed ID: 34607855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study.
    Alejandra M; Gertych W; Pomel C; Ferron G; Lusque A; Angeles MA; Lambaudie E; Rouzier R; Bakrin N; Golfier F; Glehen O; Canis M; Bourdel N; Pouget N; Colombo PE; Guyon F; Meurette J; Querleu D
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current clinical practice in cytoreductive surgery for advanced ovarian cancer: a European survey.
    Cibula D; Verheijen R; Lopes A; Dusek L;
    Int J Gynecol Cancer; 2011 Oct; 21(7):1219-24. PubMed ID: 21892096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of ESGO Quality Indicators in Cervical Cancer Surgery: A Real-World Study in a High-Volume Chinese Hospital.
    Ding Y; Zhang X; Qiu J; Zhang J; Hua K
    Front Oncol; 2022; 12():802433. PubMed ID: 35145915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unplanned 30-day hospital readmission as a quality measure in gynecologic oncology.
    Wilbur MB; Mannschreck DB; Angarita AM; Matsuno RK; Tanner EJ; Stone RL; Levinson KL; Temkin SM; Makary MA; Leung CA; Deutschendorf A; Pronovost PJ; Brown A; Fader AN
    Gynecol Oncol; 2016 Dec; 143(3):604-610. PubMed ID: 27665313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model.
    Aletti GD; Santillan A; Eisenhauer EL; Hu J; Aletti G; Podratz KC; Bristow RE; Chi DS; Cliby WA
    Gynecol Oncol; 2007 Oct; 107(1):99-106. PubMed ID: 17602726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of ovarian cancer surgery quality indicators using a modified Delphi approach.
    Gagliardi AR; Fung MF; Langer B; Stern H; Brown AD
    Gynecol Oncol; 2005 May; 97(2):446-56. PubMed ID: 15863144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study.
    Lenck C; Chopin N; Gouy S; Bonsang-Kitzis H; Martinez-Gomez C; Radosevic-Robin N; Martin S; Lefeuvre-Plesse C; Lambaudie E; Leblanc E; Guyon F; Classe JM; Ramanah R; Beurrier F; Angeles MA; Pomel C; Joly F; de la Motte Rouge T; Provansal M; Lesoin A; Floquet A; Berton D; Kalbacher E; Chakiba C; Meeus P; Selle F; Treilleux I; Lecuru F; Pautier P; Ray-Coquard I
    Gynecol Oncol; 2020 Apr; 157(1):78-84. PubMed ID: 32131977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary surgical cytoreduction in advanced ovarian cancer: An outcome analysis within the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group.
    Greggi S; Falcone F; Carputo R; Raspagliesi F; Scaffa C; Laurelli G; Giorda G; Di Vagno G; Petruzzelli F; Cormio G; Marinaccio M; Pignata S
    Gynecol Oncol; 2016 Mar; 140(3):425-9. PubMed ID: 26825616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical program building in advanced ovarian cancer: European perspective.
    Verleye L; Ottevanger PB; Vergote I
    Gynecol Oncol; 2009 Aug; 114(2 Suppl):S10-4. PubMed ID: 19573699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery for ovarian cancer: quality assessment.
    Brand AH; DiSilvestro PA; Sehouli J; Berek JS
    Ann Oncol; 2017 Nov; 28(suppl_8):viii25-viii29. PubMed ID: 29232471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups.
    Greggi S; Falcone F; Aletti GD; Cascella M; Bifulco F; Colombo N; Pignata S
    J Gynecol Oncol; 2022 Sep; 33(5):e60. PubMed ID: 35712972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery.
    Querleu D; Planchamp F; Chiva L; Fotopoulou C; Barton D; Cibula D; Aletti G; Carinelli S; Creutzberg C; Davidson B; Harter P; Lundvall L; Marth C; Morice P; Rafii A; Ray-Coquard I; Rockall A; Sessa C; van der Zee A; Vergote I; duBois A
    Int J Gynecol Cancer; 2017 Sep; 27(7):1534-1542. PubMed ID: 30814245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-operation outcome in patients referred to a gynecologic oncology center with presumed ovarian cancer FIGO I-IIIA after sub-standard initial surgery.
    Grabowski JP; Harter P; Buhrmann C; Lorenz D; Hils R; Kommoss S; Traut A; du Bois A
    Surg Oncol; 2012 Mar; 21(1):31-5. PubMed ID: 20875732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study.
    Pons-Tostivint E; Daubisse-Marliac L; Grosclaude P; Oum Sack E; Goddard J; Morel C; Dunet C; Sibrac L; Lagadic C; Bauvin E; Bergé Y; Bernard-Marty C; Vaysse C; Lacaze JLL;
    Breast; 2019 Aug; 46():170-177. PubMed ID: 31226572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter to the Editor on the "European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery" by Querleu et al, Int J Gynecol Cancer 2016;26: 1354-1363.
    Salehi S; Hjerpe E; Falconer H
    Int J Gynecol Cancer; 2018 Mar; 28(3):426-427. PubMed ID: 29384793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.